Isolation and characterization of LNCaP sublines differing in hormone sensitivity

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Prostate cancer exhibits variable androgen sensitivity.
• Understanding hormone sensitivity is crucial for treatment strategies.

Purpose of the Study:

• To isolate and characterize prostate cancer cell sublines with differential androgen sensitivity.
• To investigate the biological mechanisms underlying varying hormone sensitivity in prostate cancer.

Main Methods:

• Limiting dilution of LNCaP cells to establish sublines.
• Analysis of cell growth, PSA expression, and androgen receptor levels.
• Assessment of intracellular zinc levels and ZnT3 mRNA expression.
• In vivo tumor grafting and assessment of angiogenesis (CD31+ vessels).

Main Results:

• Isolated LNCaP-E9 (decreased growth with androgens) and LNCaP-G4 (biphasic growth with androgens) sublines.
• E9 cells showed lower PSA mRNA and protein expression and reduced androgen-stimulated PSA expression compared to G4 cells.
• ZnT3 mRNA expression was higher in E9 cells; intracellular zinc levels were similar.
• E9 tumors exhibited significantly increased angiogenesis (2.5-fold higher CD31+ vessels) compared to G4 tumors.

Conclusions:

• LNCaP-E9 cells demonstrate lower androgen sensitivity than LNCaP-G4 cells.
• Differential expression of ZnT3 and increased angiogenesis in E9 cells may contribute to altered hormone sensitivity.
• These sublines serve as valuable models for studying hormone-refractory prostate cancer biology.